SCHEMBL1865183

SCHEMBL1865183

CCN1CCN(Cc2ccn(Cc3ccccc3F)c(=O)c2O)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
VEGFA P15692 5/20 0.60
EGLN1 Q9GZT9 5/20 0.60
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
MAPK1 P28482 1/20 0.46
THRB P10828 1/20 0.46
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
TP53 P04637 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CYP2A13 Q16696 1/20 0.44
ATM Q13315 1/20 0.44
COMT P21964 1/20 0.43
DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870092 0.91 VEGFA (0.60) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1868252 0.87 VEGFA (0.57) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1770233 0.86 VEGFA (0.61) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1770481 0.86 ALDH1A1 (0.73) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1867899 0.86 VEGFA (0.59) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1868736 0.86 VEGFA (0.64) VEGFAEGLN1ALDH1A1KDM4EKMT2A
SCHEMBL1770324 0.85 KDM4E (0.58) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL272116 0.84 VEGFA (0.85) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL27866629 0.83 VEGFA (0.55) VEGFAEGLN1ALDH1A1KDM4EPOLB
SCHEMBL1770721 0.82 VEGFA (0.69) VEGFAEGLN1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496084-A1 COMPOSITIONS AND METHODS FOR TREATING COLITIS Aerpio Therapeutics Inc. (US) 2012-09-12 EP claimed
EP-2496236-A1 PROLYL HYDROXYLASE INHIBITORS Aerpio Therapeutics Inc. (US) 2012-09-12 EP claimed
WO-2011057121-A1 COMPOSITIONS AND METHODS FOR TREATING COLITIS AKEBIA THERAPEUTICS INC. (US) 2011-05-12 WO claimed
WO-2011057115-A1 PROLYL HYDROXYLASE INHIBITORS AKEBIA THERAPEUTICS INC. (US) 2011-05-12 WO claimed